people on the move
ACEA Biosciences
ACEA Biosciences, a Californian company providing cell analysis platforms to drug developers, has appointed a VP of Global Commercialisation.
Michael Honeysett previously served as Chief Business Officer at Protelica, Global Market Development Leader and Regional Sales Director for GE Healthcare, and VP of sales and marketing for Q3DM, an early cellular imaging firm.
ACEA is a private company offering seven cell analysis tools to preclinical clients, including xCELLigence for high-throughput screening and NovoCyte for flow cytometry. It also has manufacturing operations in Hangzhou, china.